About the Product

Description


Epalnest 150 Tablet containing Epalrestat 150 mg is a specialized medicine used in the management of diabetic neuropathy. It helps in reducing nerve damage, relieving symptoms like pain, burning, and numbness, and improving overall nerve function in diabetic patients.

Epalrestat works by inhibiting the aldose reductase enzyme, which plays a key role in the development of diabetic nerve damage. By controlling this pathway, it helps protect nerves from glucose-induced injury and supports nerve repair.

The formulation provides effective relief from neuropathic symptoms and helps improve quality of life in patients with long-standing diabetes. It is widely prescribed as part of comprehensive diabetic care for managing nerve-related complications.

With increasing cases of diabetic neuropathy, this product has strong demand in both neurology and diabetic segments. Its consistent prescription support, targeted action, and growing awareness make it a valuable addition for expanding reach and achieving steady growth in the neuropathy care category.

Some patients may experience dizziness, headache, drowsiness, weakness, or palpitations, especially after the first dose. These effects are usually mild and tend to improve over time. Rarely, fainting (first-dose effect) or severe hypotension may occur and require medical attention.

Prazyle XL 1 Tablet is indicated for the management of hypertension and for relieving symptoms of benign prostatic hyperplasia (BPH) such as difficulty in urination, weak stream, and frequent urination. It helps reduce blood pressure and improves urinary flow, thereby enhancing overall patient comfort and quality of life.

This medicine should be taken under medical supervision. The first dose is usually taken at bedtime to reduce the risk of dizziness or fainting. Patients should rise slowly from sitting or lying positions to avoid sudden drops in blood pressure. Inform your doctor about any other medications being taken.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Epalrestat 150mg Tablet in the PCD pharma franchise market?

Epalrestat 150mg Tablet is a specialty anti-diabetic neuropathy medicine used in nerve damage management in diabetes, making it a high-demand prescription product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.

Why should medical distributors include Epalrestat 150mg Tablets in their product range?

Medical distributors and wholesalers can benefit from consistent demand in diabetic neuropathy, nerve pain, tingling and numbness in limbs, long-term diabetes complications, and neuro-protective therapy support. It is commonly prescribed by diabetologists, neurologists, and physicians.

Does Cafoli Lifecare offer PCD pharma franchise opportunities for this product?

Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Epalrestat 150mg Tablet with monopoly rights, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.

What benefits do wholesalers get by partnering for this neuropathy product?

Wholesalers and medical agencies benefit from steady chronic prescription demand in diabetic complication management, long-term therapy usage, and strong acceptance in neurology and diabetology segments when partnering with Cafoli Lifecare.

How can I become a distributor or franchise partner for Epalrestat 150mg Tablet?

Medical distributors, stockists, wholesalers, and pharma professionals interested in this neuropathy formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, and distribution support services.